9.22.2017
2.13.2017 
1.31.2017 
1.26.2017 
I appreciate Venrock's drive to win. The firm has been a pioneer across many sectors and their continued focus on novel approaches to massive markets has made them great.
Michael Dubin
Dollar Shave Club
Candid conversations about entrepreneurship
Available on iTunes, SoundCloud and Stitcher
Our partners are an extension of our company, so we choose them carefully.
Tony Fadell and Matt Rogers
Nest
Venrock believed in us when others didn’t. They could see the magic behind our vision.
Brian O’Kelley
AppNexus
Venrock's guidance in the early days of CloudFlare was a great resource. They have been a partner ever since.
Matthew Prince, Michelle Zatlyn and
Lee Holloway
CloudFlare
I wouldn’t start another company without Venrock. They have led us through the challenging moments that make the difference between success and failure.
Gio Colella
Castlight Health
Build. Grow. Disrupt.
Venrock partners with entrepreneurs to achieve what others believe is impossible.
We Invest in Technology
- Software and Cloud Services
- Security
- Healthcare IT
- AdTech
- Consumer
- Big Data
Software and Cloud Services
We see a decade’s worth of innovation ahead as more elements of enterprise infrastructure are defined by software and move to the cloud. We continue to look for emerging leaders in these areas.
Security
Cloud services, big data and mobile technologies are creating a vast new set of security problems to be solved. We have invested in many of the leading security companies over the past 20 years and continue to invest actively in pioneering startups in the field.
Healthcare IT
The largest industry in the United States is being completely reconstructed as the twin tsunamis of incentives and information are brought to bear on an archaic system. Capitalism and information technology will create a dramatically more efficient healthcare system that provides better care.
AdTech
We have invested in many of the leading AdTech companies over the past 20 years and are looking to support the next generation of disruptive innovators taking advantage of the revolutions in mobile, social, video and big data.
Consumer
The parallel revolutions in mobile, social, and broadband have created fertile ground for consumer startups, as digital technology permeates almost every sphere of daily life. We seek to support entrepreneurs with disruptive ideas that can help transform the way we live.
Big Data
Over 90% of the world’s data has been created in the past two years, and new data generation continues to grow at an exponential rate, creating unprecedented opportunities to disrupt existing industries and create new ones based on the insights this data provides. We are actively looking for the top entrepreneurs and biggest ideas in this area.
We Invest in Private Healthcare
- Therapeutics-Small Molecules
- Therapeutics-Biologics
- Medical Devices
- Diagnostics & New Technologies
Therapeutics-Small Molecules
Leveraging novel biology and advances in chemistry, we seek out the most revolutionary small molecule therapeutics and platforms that have the opportunity to create large shareholder value and save millions of lives.
Therapeutics-Biologics
Drawing on decades of experience funding many of the leaders in biotechnology, we continue to invest in proteins and antibodies, as well as new therapeutic modalities, that target diseases unattainable or poorly treated by small molecules.
Medical Devices
Today, there are very interesting opportunities for novel, innovative device interventions to address complex diseases, as well as consumer appetites.
Diagnostics & New Technologies
The industrialization of DNA sequencing over the last decade has created robust and cost efficient methods to diagnose and monitor disease via molecular diagnostics. The next decade will be even more fruitful, with novel technologies and content creating ever more powerful products to assist in the treatment of patients.
We Invest in Public Healthcare
Be early. Be insightful. Drive to consensus.
Venrock Healthcare Capital Partners (VHCP) is a fund dedicated to investments in publicly held development stage and late-stage private healthcare companies. Our investment approach is uniquely applicable to evaluate these types of companies as potential investment opportunities. We leverage our venture expertise, rigorous data analysis and long-term supportive orientation to support successful biotech companies within the public markets.
Insights
News
Investment Team
Contact
Silicon Valley
3340 Hillview Avenue,
Palo Alto, California 94304
Phone 650 561 9580
Fax 650 561 9180
New York
530 Fifth Avenue, 22nd Floor,
New York, New York 10036
Phone 212.444.4100
Fax 212.444.4101
Boston
34 Farnsworth St, 3rd Floor,
Boston, MA 02210
Phone 617.995.2000
Fax 617.995.2001